Sanofi successfully prices EUR 1.5 billion of bond issue Paris, March 5, 2025. Sanofi announces that it has successfully priced its offering of ...
The Manila Times on MSN1h
PAO: Garin withheld Dengvaxia's fatal risksTHE Public Attorney's Office (PAO) told a Quezon City-Regional Trial Court that the death of many children allegedly due to ...
South Africa's Competition Commission is investigating drugmakers Novo Nordisk and Sanofi over possible anti-competitive ...
Zandy Forbes’ biotech company MeiraGTx has developed targeted gene therapy methods to treat more than just genetic disorders.
The last few years have been tough for the insulin market, with recent policies and high-level pressure forcing companies to ...
Tolebrutinib is more effective in reducing the risk of disability progression in MS patients with paramagnetic rim lesions, ...
South Africa's Competition Commission investigates Novo Nordisk and Sanofi for potential anti-competitive practices in the insulin pen market.
South Africa's competition watchdog launches a crucial investigation into pharmaceutical giants Novo Nordisk and Sanofi over ...
Berenberg Bank analyst Luisa Hector maintained a Buy rating on Sanofi (SNY – Research Report) yesterday and set a price target of $63.00. The ...
South Africa's competition watchdog is investigating drugmakers Novo Nordisk and Sanofi over possible anti-competitive ...
Its Reg S/144A deal, led by Citigroup, Crédit Agricole, ING and MUFG as global coordinators and physical bookrunners, is a ...
Novo Nordisk A/S and Sanofi are facing an investigation in South Africa over concerns about potential anti-competitive practices in the human insulin pen market.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback